Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

7.8K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.8K
Cancer Therapies02:49

Cancer Therapies

10.1K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.1K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

8.9K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.9K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

6.0K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
6.0K
Normal Stress01:19

Normal Stress

1.4K
Normal stress is a type of stress that occurs when forces act perpendicular, or normal, to a material's cross-sectional area. This stress often arises in structures when subjected to axial loading, which is the application of force along the axis of an object. A practical example of this can be found in bridge truss members.
When a rod is under axial loading, the internal forces and corresponding stress are normal to the plane of the section, so it is termed normal stress. It's important to...
1.4K
Normal Distribution01:11

Normal Distribution

17.2K
The normal, a continuous distribution, is the most important of all the distributions. Its graph is a bell-shaped symmetrical curve, which is observed in almost all disciplines. Some of these include psychology, business, economics, the sciences, nursing, and, of course, mathematics. Some instructors may use the normal distribution to help determine students’ grades. Most IQ scores are normally distributed. Often real-estate prices fit a normal distribution. The normal distribution is...
17.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Antibody-drug conjugates in gynaecological cancers: opportunities and challenges.

Nature reviews. Clinical oncology·2026
Same author

First-In-Human Trial of Encapsulated Cells Constitutively Expressing Localized IL-2 in Patients with High-Grade Serous Ovarian Carcinoma.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same author

Characterizing the effects of anti-PD1 immunotherapy on ataxia in a vestibular schwannoma mouse model.

Journal of neuro-oncology·2026
Same author

Characterizing Tumor-Induced Ataxia in a Vestibular Schwannoma Mouse Model.

Journal of visualized experiments : JoVE·2026
Same author

A cochlea-sparing strategy for non-invasive control of intracranial schwannomas via peripheral irradiation and anti-PD-1 therapy enhanced by STING activation.

Theranostics·2026
Same author

NKG2D upregulation sensitizes tumors to combined anti-PD1 and anti-VEGF therapy and prevents hearing loss.

Nature communications·2026

Related Experiment Video

Updated: Jan 29, 2026

An Orthotopic Model of Serous Ovarian Cancer in Immunocompetent Mice for in vivo Tumor Imaging and Monitoring of Tumor Immune Responses
10:35

An Orthotopic Model of Serous Ovarian Cancer in Immunocompetent Mice for in vivo Tumor Imaging and Monitoring of Tumor Immune Responses

Published on: November 28, 2010

18.8K

Normalizing the Tumor Microenvironment: A New Frontier in Ovarian Cancer Therapy.

Adam P Jones1, Yanxia Zhao2, Bo R Rueda3

  • 1Edwin L. Steele Laboratories, Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA.

International Journal of Molecular Sciences
|January 28, 2026
PubMed
Summary

Tumor microenvironment (TME) normalization therapies show promise for treating advanced ovarian cancer. These approaches enhance chemotherapy and immunotherapy effectiveness, offering a new strategy for this deadly gynecological malignancy.

Keywords:
extracellular matriximmunotherapymetastasisovarian cancertumor microenvironment

More Related Videos

In vitro Enrichment of Ovarian Cancer Tumor-initiating Cells
11:37

In vitro Enrichment of Ovarian Cancer Tumor-initiating Cells

Published on: February 18, 2015

14.2K
A Brain Tumor/Organotypic Slice Co-culture System for Studying Tumor Microenvironment and Targeted Drug Therapies
10:13

A Brain Tumor/Organotypic Slice Co-culture System for Studying Tumor Microenvironment and Targeted Drug Therapies

Published on: November 7, 2015

11.6K

Related Experiment Videos

Last Updated: Jan 29, 2026

An Orthotopic Model of Serous Ovarian Cancer in Immunocompetent Mice for in vivo Tumor Imaging and Monitoring of Tumor Immune Responses
10:35

An Orthotopic Model of Serous Ovarian Cancer in Immunocompetent Mice for in vivo Tumor Imaging and Monitoring of Tumor Immune Responses

Published on: November 28, 2010

18.8K
In vitro Enrichment of Ovarian Cancer Tumor-initiating Cells
11:37

In vitro Enrichment of Ovarian Cancer Tumor-initiating Cells

Published on: February 18, 2015

14.2K
A Brain Tumor/Organotypic Slice Co-culture System for Studying Tumor Microenvironment and Targeted Drug Therapies
10:13

A Brain Tumor/Organotypic Slice Co-culture System for Studying Tumor Microenvironment and Targeted Drug Therapies

Published on: November 7, 2015

11.6K

Area of Science:

  • Oncology
  • Gynecologic Oncology
  • Cancer Immunology

Background:

  • Ovarian cancer is a leading cause of gynecologic cancer death, often diagnosed at advanced stages.
  • Recurrent ovarian cancer is difficult to treat due to resistance to chemotherapy and a complex tumor microenvironment (TME).
  • The TME in ovarian cancer features abnormal vasculature, dense extracellular matrix, hypoxia, and immune suppression, hindering treatment efficacy.

Purpose of the Study:

  • To review the application of tumor extracellular matrix normalizing therapies in preclinical models of advanced ovarian cancer.
  • To evaluate the synergistic benefits of TME normalization with chemotherapy and immunotherapy.
  • To highlight TME normalization as a potential therapeutic strategy for ovarian cancer.

Main Methods:

  • Review of preclinical studies on tumor extracellular matrix normalizing therapies in advanced ovarian cancer models.
  • Analysis of the impact of these therapies on chemotherapy and immunotherapy efficacy.
  • Discussion of the role of TME normalization in overcoming treatment resistance and immunosuppression.

Main Results:

  • Tumor extracellular matrix normalizing therapies demonstrate synergistic effects when combined with chemotherapy.
  • These therapies enhance the efficacy of immunotherapy in preclinical ovarian cancer models.
  • TME normalization strategies show potential to overcome treatment resistance and improve therapeutic outcomes.

Conclusions:

  • Normalization of the tumor microenvironment is a promising therapeutic strategy for advanced ovarian cancer.
  • Combining TME normalizing therapies with chemotherapy and immunotherapy could improve patient prognosis.
  • Further research into TME normalization is warranted to translate these findings into clinical practice.